Groups A-Z
Group name
View funds in this group

News & Research

PIMCO

Fresh start for a laggard: Does the Artemis era make Murray Income worth buying?

Matteo Anelli
12 March 2026
Adrian Frost and his team are now running a trust at a discount – is this a chance to buy?

Fidelity's perfect ISA portfolio using its own best-buy funds

Matteo Anelli
11 March 2026
Fidelity's investment director picks funds for four types of investor.

Why this top multi-asset fund has halved its bond allocation since 2022

Jonathan Jones
10 March 2026
The managers have turned back to alternative assets.

Making hay in the sunshine as biotech’s outlook brightens

Ailsa Craig and Marek Poszepczynski
10 March 2026
After a turbulent 2025, the International Biotechnology Trust managers see improving M&A activity, stronger financing markets and a more pragmatic FDA as reasons for optimism.

Fundswire

Performance Tables

Contact Details

Standard Life House, 30 Lothian Road, Edinburgh, EH1 2DH

-

www.standardlife.com

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.